Training on Optimization of Behavioral and Biobehavioral Interventions
Topic: Optimization of Behavioral and Biobehavioral Interventions
Date: May 16-20, 2016
Venue: Bethesda North Marriott Hotel & Conference Center, North Bethesda, MD
Sponsors: Office of Behavioral and Social Science Research (OBSSR) and National Institute on Drug Abuse (NIDA)
The goal of this five-day training is to help attendees gain the skills they need to use the multiphase optimization strategy (MOST) to optimize behavioral and biobehavioral interventions. Optimization of fixed (traditional), adaptive, and just-in-time adaptive interventions will be covered.
Time will be spent in lecture and discussion. The team of instructors and presenters includes both methodologists and intervention scientists. Time will be set aside for attendees to meet individually with instructors and presenters about their work. The last day will include a panel discussion in which NIH program officers talk about how to obtain funding to conduct optimization of behavioral and biobehavioral interventions.
One year of graduate-level statistics, which should include training through multiple regression, is a prerequisite. Some training in the randomized controlled trial (RCT) and experience with development of behavioral or biobehavioral interventions are also needed.
Topics to be covered:
- multiphase optimization strategy (MOST)
- adaptive interventions
- sequential, multiple assignment, randomized trial (SMART)
- just-in-time adaptive interventions (JITAIs)
- factorial and fractional factorial screening experiments
- obtaining funding for optimization projects
The application period is closed.
Enrollment is limited to 30 participants to maintain an informal atmosphere and to encourage interaction. Priority will be given to individuals who have the appropriate statistical background and for whom the topic will have direct relevance to their work.
The registration fee of $400 for the five-day training covers all instruction, program materials, refreshment breaks, and lunch each day. A waiver of the registration fee is available for a limited number of individuals to maximize minority representation and support early-career scientists. To attend the training, an application was required by Monday, February 29, 2016. The deadline has now passed. Applicants will be notified about decisions by Friday, March 18, 2016.
Once accepted, participants will be emailed instructions about how to register.
U.S. citizens and permanent residents will be given an allowance of up to $2500 per participant to defray travel and lodging expenses. Others, please contact Tina Meyers (firstname.lastname@example.org) for more information.
Review our refund, access, and cancellation policies.
Instructors will deliver the primary portion of the curriculum. Presenters are intervention scientists who will share their experience with applications of the methods covered in the curriculum.
Daniel Almirall, Ph.D.
Research Assistant Professor in the Institute of Social Research, University of Michigan
Investigator, The Methodology Center
Daniel Almirall is interested in methods and study designs used to form adaptive interventions (AIs). AIs can be used to inform individualized treatment guidelines for the on-going management of chronic illnesses or disorders such as drug abuse, depression, autism, obesity, or HIV/AIDS. Dr. Almirall works on methods for the design and analysis of sequential multiple assignment randomized trials (SMARTs) which can used to build and optimize AIs. He is also interested in the development of methods for causal inference in which treatments, covariates, and outcomes are all time-varying.
Linda M. Collins, Ph.D.
Director, The Methodology Center
Distinguished Professor of Health and Human Development and Professor of Statistics, Penn State
Linda M. Collins' is the primary developer of the multiphase optimization strategy (MOST), a comprehensive, principled, engineering-inspired framework for developing, optimizing, and evaluating multicomponent behavioral and biobehavioral interventions. She collaborates with intervention scientists (including presenters Dr. Kugler, Dr. Piper, Dr. Spring, and Dr. Wyrick) to develop optimized interventions in a broad range of fields including tobacco cessation, weight reduction, and prevention of sexually transmitted infections.
Susan Murphy, Ph.D.
H.E. Robbins Professor of Statistics, Research Professor in the Institute for Social Research, and Professor of Psychiatry, University of Michigan
Principal Investigator, The Methodology Center
Susan Murphy's research focuses on improving sequential, individualized, decision making in health, in particular on clinical trial design and data analysis to inform the development of mobile health treatment policies. Susan is a Fellow of the Institute of Mathematical Statistics, a Fellow of the College on Problems in Drug Dependence, a former editor of the Annals of Statistics, a member of the US National Academy of Medicine and a 2013 MacArthur Fellow.
Pedja Klasnja, Ph.D.
Assistant Professor in the School of Information, University of Michigan
Predrag "Pedja" Klasnja works at the intersection of Human-Computer Interaction and Health Informatics, and he studies how mobile technologies can help individuals manage their health in everyday life and make lifestyle changes needed to improve their health. He is particularly interested in the design and evaluation of just-in-time adaptive interventions. Pedja holds a Ph.D. in Information Science from the University of Washington. Following his PhD, he was a National Library of Medicine Postdoctoral Fellow in Biomedical and Health Informatics at the University of Washington School of Medicine.
Kari Kugler, Ph.D.
Research Associate at The Methodology Center
Kari Kugler researches the development of effective and efficient behavioral interventions targeting a wide range of health behaviors among various populations and contexts. In particular, she is focused on developing interventions targeting the intersection of sexual and reproductive health, including HIV, alcohol use and obesity among adolescents and young adults. Dr. Kugler collaborates with methodologists and intervention scientists on projects using the multiphase optimization strategy (MOST), including the itMatters project with Dr. Collins and Dr. Wyrick.
James McKay, Ph.D.
Professor of Psychology in Psychiatry at the University of Pennsylvania; Director, Penn Center on the Continuum of Care in the Addictions,
Director, Philadelphia VA Center of Excellence in Substance Abuse Treatment and Education (CESATE)
James McKay's work has included evaluations of continuing care treatments for alcohol and cocaine use disorders, evaluations of ASAM and other patient placement criteria, development of adaptive interventions for substance use disorders, and the identification of factors that predict relapse following substance abuse treatment. Dr. McKay’s current research efforts are focused on the development and evaluation of adaptive approaches to the management of addiction and the use of mobile health technology to augment and extend treatment interventions.
Megan Piper, Ph.D.
Assistant Professor in the University of Wisconsin Department of Medicine
Associate Director of Research at UW-Center for Tobacco Research and Intervention
Megan Piper’s research focuses on understanding and treating tobacco dependence, with an additional interest in different populations of smokers who have more difficulty quitting, such as women and smokers with mental illness. Dr. Piper began her work at UW-CTRI in 1999 when she collaborated on the Public Health Service Guideline: Treating Tobacco Use and Dependence that was published in 2000. She then served as the Project Scientist for the 2008 PHS Guideline update.
Bonnie Spring, Ph.D.
Director, Institute for Public Health and Medicine (IPHAM) at Northwestern University's Feinberg School of Medicine Center for Behavior and Health
Professor of Behavioral Medicine and Psychiatry and Behavioral Sciences at Northwestern University
Dr. Spring's work explores the efficacy of interventions on diet, exercise, and sedentary behaviors using feedback supplied via handheld technology. She is PI with Linda Collins on the NIDDK-funded R01 "Opt-In: Optimizing Intensive Intervention for Weight Loss." In this project, the researchers are employing the multiphase optimization strategy (MOST) to develop a resource-efficient, Internet-and-phone based, weight-loss intervention
David Wyrick, Ph.D.
Director of the Institute for the Promotion of Athlete Health & Wellness at University of North Carolina at Greensboro
Associate Professor of Public Health Education at University of North Carolina Greensboro's School of Health & Human Sciences
Dr. Wyrick is an Associate Professor of Public Health Education at the University of North Carolina at Greensboro (UNCG) where he founded and directs the Institute to Promote Athlete Health & Wellness. Dr. Wyrick has extensive experience in prevention research, evaluation, and intervention development. He recently completed a study that implemented MOST to optimize myPlaybook, an alcohol and other drug prevention program for collegiate student-athletes. myPlaybook is currently being used by more than 400 colleges nationally. He is currently collaborating with Drs. Collins and Kugler on another MOST project to optimize itMatters, an online intervention to reduce sexually transmitted diseases on college campuses.
Bill Riley (Office of Behavioral and Social Science Research), Bob Freeman (National Institute on Alcohol Abuse and Alcoholism), Glen Morgan (National Cancer Institute), and Soshana Kahana (National Institute on Drug Abuse) will participate in the panel discussion about obtaining funding.
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
North Bethesda, MD 20852
Funding for this conference was made possible by P50 DA039838 from the National Institute on Drug Abuse (NIDA) and support from the Office of Behavioral and Social Science Research (OBSSR). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.